The Comprehensive Guide to Dacarbazine 200mg Injection In the specialized field of oncology, Dacarbazine 200mg Injection (also known as DTIC) remains a cornerstone chemotherapy agent for the treatment of aggressive malignancies. As a premier pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this vital antineoplastic drug is delivered with precision to healthcare systems in London, New York, Sydney, Johannesburg, and beyond. Product Specifications Brand Name: Ernest-Oncology (Dacarbazine) Strength: 200 mg / vial Dosage Form: Lyophilized Powder for Injection Primary Indications: Metastatic malignant melanoma and Hodgkin’s Lymphoma. Storage: Store at 2°C to 8°C (36°F to 46°F) and protect from light. Mechanism of Action: How It Works DNA Damage: It works by damaging the genetic material (DNA and RNA) of cancer cells. It specifically acts as a purine analog, interfering with DNA synthesis. Cell Cycle Impact: While it is a non-cell-cycle-specific agent, its primary action is to stop the growth and multiplication of rapidly dividing malignant cells, eventually leading to cell death. Therapeutic Indications & Administration Malignant Melanoma: Used as palliative therapy for skin cancer that has spread to other parts of the body. Hodgkin’s Disease: Often used as a second-line therapy in combination with other effective agents (e.g., as part of the ABVD regimen). Soft Tissue Sarcomas: Frequently utilized in advanced adult soft tissue sarcomas. Administration: * Intravenous Route: It is administered only by a qualified healthcare professional as a slow IV infusion. Vesicant Warning: Dacarbazine is a potent vesicant; extreme care must be taken to avoid extravasation (leakage into surrounding tissue), which can cause severe pain and tissue damage. Clinical Side Effects & Safety Gastrointestinal Distress: Nausea and vomiting are very common (occurring in over 90% of patients initially). Symptoms usually subside after 1–2 days of treatment. Bone Marrow Suppression: It can lead to severe decreases in white blood cells (leukopenia) and platelets (thrombocytopenia), significantly increasing the risk of infection and bleeding. Flu-like Syndrome: Fever, muscle pain, and malaise may occur during or after the treatment. Photosensitivity: Patients should avoid direct sunlight, as the drug can increase skin sensitivity to UV rays. Contraindications: Strictly contraindicated in patients with severe hepatic or renal impairment and during pregnancy or breastfeeding due to the high risk of fetal harm. Why Source from Ernest Oncology? United Kingdom (London): Supplying cost-effective oncology solutions for specialized clinics and hospitals. USA: Delivering bulk quantities that meet international safety and documentation standards. Australia: Ensuring stable access through established “Special Access Scheme“ (SAS) supply chains. South Africa: Bridging critical gaps in the oncology market with reliable, high-tier pharmaceutical exports from India. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383